Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk

NCT04371926 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Concerned about the adverse effects of HCQ

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine Sulfate

Sponsor

Texas Cardiac Arrhythmia Research Foundation